K852767

Substantially Equivalent

ERYTHOCYTE CREATINE

Applicant: Panmed, Inc.
Product code: JLA
Advisory panel: Clinical Chemistry
Date received: 1985-06-28
Decision date: 1986-11-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Three Oaks, MI, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.